1. Home
  2. WKSP vs SNGX Comparison

WKSP vs SNGX Comparison

Compare WKSP & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worksport Ltd.

WKSP

Worksport Ltd.

HOLD

Current Price

$0.82

Market Cap

13.2M

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.41

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKSP
SNGX
Founded
2003
1987
Country
United States
United States
Employees
81
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
11.2M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
WKSP
SNGX
Price
$0.82
$0.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$9.25
$6.00
AVG Volume (30 Days)
380.8K
1.4M
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.03
EPS
N/A
N/A
Revenue
N/A
$119,371.00
Revenue This Year
$131.96
N/A
Revenue Next Year
$24.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$0.28
52 Week High
$4.90
$6.23

Technical Indicators

Market Signals
Indicator
WKSP
SNGX
Relative Strength Index (RSI) 30.61 31.28
Support Level N/A N/A
Resistance Level $1.44 $1.48
Average True Range (ATR) 0.10 0.06
MACD -0.02 -0.01
Stochastic Oscillator 9.25 11.22

Price Performance

Historical Comparison
WKSP
SNGX

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: